跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 205 条关于
“aHUS”
全部
205
临床试验
144
药物
13
机构
13
资讯
35
去年
Early Platelet Count Changes Predict Ultomiris Response in aHUS Patients
去年
Alexion Launches Interactive Storybook to Help Children Understand Rare Kidney Disease aHUS
2年前
FDA Approves Epysqli, an Eculizumab Biosimilar for PNH and aHUS
去年
Clinical Trials Advance Treatment for Rare Blood Disease aHUS, Offering Hope for Patients
去年
Newcastle Study Shows Safe Withdrawal of Eculizumab in Rare Kidney Disease, Saving NHS £4.2 Million Per Patient
去年
Teva and Samsung Bioepis Launch Epysqli, a 30% Discounted Biosimilar to Soliris for Rare Diseases
2年前
FDA Lifts Clinical Hold on 4D Molecular Therapeutics' Fabry Disease Gene Therapy Trial
去年
Alexion Launches Phase 3 Trial of Ultomiris for Severe COVID-19 Pneumonia
去年
Breakthrough Treatments Transform Landscape for Rare Hemolytic Anemias: From C5 Inhibitors to Novel Therapeutic Approaches
去年
FDA Approves Soliris for Refractory Myasthenia Gravis, First New Treatment in 60 Years
第 1 页,共 4 页
上一页
下一页